Austar Lifesciences Limited (6118.HK)
HKD 0.79
(0.0%)
HKD 0.79
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.06 CNY | -229.41% |
| 2022 | 0.17 CNY | -68.52% |
| 2021 | 0.54 CNY | 735.91% |
| 2020 | 0.06 CNY | 308.86% |
| 2019 | 0.02 CNY | 7800.0% |
| 2018 | 0.00 CNY | 100.18% |
| 2017 | -0.11 CNY | -202.2% |
| 2016 | -0.04 CNY | -391.2% |
| 2015 | 0.01 CNY | -92.65% |
| 2014 | 0.17 CNY | 21.43% |
| 2013 | 0.14 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.01 CNY | 0.0% |
| 2023 FY | - CNY | -229.41% |
| 2023 Q2 | -0.08 CNY | -196.75% |
| 2022 Q2 | 0.09 CNY | -18.73% |
| 2022 Q4 | 0.08 CNY | -10.51% |
| 2022 FY | - CNY | -68.52% |
| 2021 Q2 | 0.43 CNY | 985.86% |
| 2021 FY | - CNY | 735.91% |
| 2021 Q4 | 0.11 CNY | -74.42% |
| 2020 Q4 | 0.04 CNY | 98.0% |
| 2020 Q2 | 0.02 CNY | 159.74% |
| 2020 FY | - CNY | 308.86% |
| 2019 Q2 | 0.01 CNY | 8.0% |
| 2019 FY | - CNY | 7800.0% |
| 2019 Q4 | 0.01 CNY | -4.94% |
| 2018 Q2 | -0.01 CNY | 83.33% |
| 2018 Q4 | 0.01 CNY | 175.0% |
| 2018 FY | - CNY | 100.18% |
| 2017 FY | - CNY | -202.2% |
| 2017 Q4 | -0.06 CNY | -20.0% |
| 2017 Q2 | -0.05 CNY | -290.63% |
| 2016 FY | - CNY | -391.2% |
| 2016 Q2 | -0.02 CNY | -137.0% |
| 2016 Q4 | -0.01 CNY | 45.99% |
| 2015 FY | - CNY | -92.65% |
| 2015 Q4 | -0.01 CNY | -150.51% |
| 2015 Q2 | 0.02 CNY | -74.74% |
| 2014 FY | - CNY | 21.43% |
| 2014 Q4 | 0.08 CNY | -10.19% |
| 2014 Q2 | 0.09 CNY | 94.0% |
| 2013 Q2 | 0.10 CNY | 166.11% |
| 2013 Q4 | 0.04 CNY | -52.63% |
| 2013 FY | - CNY | 0.0% |
| 2012 Q4 | 0.04 CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 0.09 HKD | 171.702% |